GA
Greenspring Associates Portfolio holdings
AUM
$1.48B
1-Year Est. Return
61.93%
This Fund
S&P 500
1 Year Est. Return
+61.93%
AUM
$126M
AUM Growth
+$48.7M
(+63%)
Holding
13
Top Buys
| 1 | +$16.7M | |
| 2 | +$3.17M | |
| 3 | +$487K | |
| 4 |
FINV
FinVolution Group
FINV
|
+$137K |
| 5 |
Pulmonx
LUNG
|
+$32.5K |
Top Sells
| 1 | +$11.7M | |
| 2 | +$3.8M | |
| 3 | +$1.55M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$213K |
| 5 |
Progyny
PGNY
|
+$57K |
Sector Composition
| 1 | Healthcare | 47.59% |
| 2 | Financials | 20.22% |
| 3 | Technology | 2.17% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $45.7M | 36.38% |
1,573,357
|
|
||
|
TWAV
2
TaoWeave Inc
TWAV
$5.62M
| $25.2M | 20.08% |
+6,154
|
|
||
3
Phathom Pharmaceuticals
PHAT
$894M
| $13.6M | 10.78% |
360,939
|
|
||
4
CrowdStrike
CRWD
$101B
| $2.73M | 2.17% |
+14,980
|
|
||
5
10x Genomics
TXG
$2.85B
| $511K | 0.41% |
+2,821
|
|
||
|
FINV
6
FinVolution Group
FINV
$1.22B
| $180K | 0.14% |
+25,737
|
|
||
|
7
Pulmonx
LUNG
$56.2M
| $26K | 0.02% |
+566
|
|
||
8
AnaptysBio
ANAB
$1.66B
| – | – |
-176,894
|
|
||
|
CMRC
9
Commerce.com Inc Series 1
CMRC
$224M
| – | – |
-24,094
|
|
||
|
10
IDEAYA Biosciences
IDYA
$2.88B
| – | – |
-15,234
|
|
||
|
11
Progyny
PGNY
$1.36B
| – | – |
-1,338
|
|
||
12
The RealReal
REAL
$1.09B
| – | – |
-600,664
|
|